MFIM
NVO

Mesirow Financial Investment Management’s Novo Nordisk NVO Stock Holding History

Mesirow Financial Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+4,357
New +$187K ﹤0.01% 496
2026
Q1 		– Sell
-4,134
Closed -$210K – 528
2025
Q4 		$210K Sell
4,134
-6,320
-60% -$323K ﹤0.01% 459
2025
Q3 		$580K Buy
10,454
+111
+1% +$6.5K 0.01% 355
2025
Q2 		$714K Sell
10,343
-1,681
-14% -$114K 0.01% 301
2025
Q1 		$835K Sell
12,024
-65
-0.5% -$5.37K 0.02% 277
2024
Q4 		$1.04M Buy
12,089
+479
+4% +$51.8K 0.02% 257
2024
Q3 		$1.38M Buy
11,610
+763
+7% +$102K 0.03% 230
2024
Q2 		$1.55M Sell
10,847
-1,310
-11% -$174K 0.03% 212
2024
Q1 		$1.56M Buy
12,157
+980
+9% +$117K 0.04% 209
2023
Q4 		$1.16M Buy
+11,177
New +$1.11M 0.04% 208

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mesirow Financial Investment Management's NVO Position: Q2 2026 in Review

Mesirow Financial Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,357 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #496 among its holdings. This is a return to the name: Mesirow Financial Investment Management previously reported a position in NVO as recently as Q4 2025.

Mesirow Financial Investment Management first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.56M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mesirow Financial Investment Management held 4,357 shares of Novo Nordisk worth $209K as of Q2 2026.
  • Novo Nordisk was a new Mesirow Financial Investment Management position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #496 holding.
  • Mesirow Financial Investment Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Mesirow Financial Investment Management's Novo Nordisk position peaked at $1.56M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.